Two years into his diagnosis, Ted’s health and quality of life plummeted. As a last resort to slow the disease’s progress, Ted participated in an experimental procedure that was not approved by the FDA. His doctors told him the treatment would not help. The procedure was part of the FDA’s initial testing phase, which is designed to prove only safety, not effectiveness.
|Raymond J. March is a Research Fellow at the Independent Institute and Assistant Professor of Economics at San José State University.|